Combangio

California, United States

Combangio is a clinical-stage biotechnology company focused on developing regenerative biotherapeutics.

$15.0M raised

Apr 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Combangio raised?

Combangio has raised $15.0M in total funding. The most recent round was Grant. The last funding was announced in April 2023.

Who are Combangio's investors?

Combangio's investors include California Institute for Regenerative Medicine.

Where is Combangio headquartered?

Combangio is headquartered in California, United States.

What does Combangio do?

Combangio is a clinical-stage biotechnology company focused on developing regenerative biotherapeutics.

What stage is Combangio at?

Combangio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2023.

MLA

"Combangio — Funding & Investors." VCBacked, April 28, 2023, https://www.vcbacked.co/company/combangio. Accessed July 3, 2026.

APA

VCBacked. (2023). Combangio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/combangio

Wikipedia (cite web)

{{cite web |title=Combangio — Funding & Investors |url=https://www.vcbacked.co/company/combangio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2023.